The performance of companies tied to blockbuster drugs like Viagra presents a challenging investment scenario . While the initial boom of copyright, fueled by Viagra's extraordinary popularity, generated substantial returns, the patent expiration in key territories has introduced substantial volatility. Investors are now grappling with the effect o